A.I.O.

This Week In Medicine

Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered! Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you. Each episode offers a filtered and concentrated summary of key journal articles, allowing you to stay informed without the need to sift through pages of research papers. W...

Auteur

A.I.O.

Catégorie

Health

Site du podcast

redcircle.com

Dernier épisode

9 juil. 2026

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android 5 M+ de téléchargements · note de 4,8 iOS bientôt

Épisodes

JAMA 4 2026 Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy. 13.04.2026

This study utilized computer simulations to evaluate whether monitoring Apolipoprotein B (apoB) is a more efficient and affordable way to prevent heart disease compared to traditional cholesterol markers. Researchers found that while tracking non-HDL cholesterol saves money over standard LDL-C methods, prioritizing an apoB goal provides the greatest health benefits by extending life expectancy. Al...

JAMA 4 2026 Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy 13.04.2026

This study investigated whether older adults who previously had benign growths called adenomas were at a higher risk for developing colorectal cancer compared to those with clear past screenings. While the research confirmed that a history of adenomas does slightly increase the likelihood of future malignancy, the overall risk of cancer death remains remarkably low for patients over the age of 75....

JAMA 4 2026 Real-World Outcomes of Transcatheter Tricuspid Valve Replacement Analysis From the STS/ACC TVT Registry 13.04.2026

This study investigates the real-world safety and effectiveness of transcatheter tricuspid valve replacement (TTVR) for patients suffering from severe heart valve leakage. By analyzing data from over a thousand patients, researchers found that this minimally invasive procedure achieved a near-complete elimination of tricuspid regurgitation in the vast majority of cases. These technical successes t...

NEJM 4 2026 Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. 09.04.2026

This study evaluates whether patients with stable heart function can safely stop taking long-term beta-blocker therapy after recovering from a heart attack. Researchers conducted a clinical trial to determine if discontinuing the medication was just as safe as continuing it for those who had already been on the treatment for at least one year. The findings revealed that stopping the drug did not i...

NEJM 4 2026 eft Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation 09.04.2026

This study evaluates whether a mechanical procedure to seal the heart's left atrial appendage is as effective as standard drug treatments for preventing strokes and deaths in high-risk patients. Researchers conducted a randomized trial to see if this surgical alternative could match the safety and efficacy of best medical care for individuals prone to both clotting and bleeding. After monitori...

NEJM 4 2026 Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease 09.04.2026

This study investigated whether pushing LDL cholesterol levels even lower than current standard targets provides better protection for people already living with heart disease. By comparing a strict target of less than 55 mg per deciliter against a more traditional goal of 70 mg per deciliter, researchers found that the more aggressive strategy significantly reduced the risk of major cardiovascula...

NEJM 4 2026 Multifaceted Strategies for Hypertension Control in Low-Income Patients 08.04.2026

This study investigates how a multifaceted, team-based approach can effectively lower blood pressure among low-income and minority populations who face significant health disparities. Researchers compared a comprehensive intervention—which integrated health coaching, home monitoring, and clinical protocols—against standard medical education for physicians. The results demonstrated that this collab...

NEJM 4 2026 Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer 08.04.2026

This study evaluates a new treatment strategy for patients with muscle-invasive bladder cancer who cannot undergo standard cisplatin chemotherapy, a group traditionally limited to surgical intervention. By combining an antibody-drug conjugate with an immunotherapy agentboth before and after surgery, researchers observed a dramatic increase in event-free and overall survival compared to surgery alo...

NEJM 3 26 26 Dengue Suppression by Male Wolbachia-Infected Mosquitoes. 28.03.2026

This research study explores a biological method for controlling dengue fever in Singapore by releasing specially infected male mosquitoes into the environment. These males carry a bacterium called Wolbachia, which ensures that any offspring produced from mating with wild females are nonviable, effectively crashing the local mosquito population. Over a two-year period, the experiment successfully...

NEJM 3 26 26 Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years 28.03.2026

This study investigates whether proactive medical intervention or watchful waiting provides better long-term outcomes for patients with severe aortic stenosis who do not yet show symptoms. Researchers compared a strategy of early surgical intervention against traditional conservative care by monitoring patient health outcomes over a ten-year period. The data revealed that patients who underwent su...

NEJM 3 26 26 Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer 28.03.2026

his clinical study investigates whether adding the immunotherapy drug atezolizumab to standard chemotherapy significantly benefits patients recovering from high-risk, stage III colon cancer with specific genetic deficiencies. Researchers compared a traditional drug cocktail against a combination treatment followed by extended immunotherapy to see if it could better prevent cancer recurrence. The r...

Lancet March 2026 Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study 17.03.2026

This international study investigates the clinical landscape for immunocompromised individuals suffering from acute respiratory failure, a primary driver of intensive care admissions. By analyzing nearly ten thousand patients across twenty-six countries, researchers identified that infectionand malignancies are the most common underlying triggers, resulting in a high thirty-day mortality rate of o...

Lancet March 2026 The effectiveness of HPV vaccination against invasive cervical cancer and related precancerous lesions: a multinational target trial emulation study 17.03.2026

By analyzing extensive healthcare data from the United Kingdom, Spain, and Norway, this study evaluates how well HPV vaccination programs protect young women against serious cervical disease over a fifteen-year period. Researchers utilized a target trial emulation to compare health outcomes between vaccinated and unvaccinated individuals, specifically focusing on the prevention of high-grade preca...

NEJM March 12 2026 Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia 12.03.2026

This study evaluates whether time-limited drug combinations are as effective as lifelong daily medication for patients newly diagnosed with chronic lymphocytic leukemia. By comparing three specific drug regimens over a three-year period, researchers found that the shorter, fixed-duration treatments performed just as well at keeping the cancer from progressing as the standard continuous therapy. No...

NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia 12.03.2026

This study investigates the effectiveness of the drug romiplostim in managing a frequent cancer treatment complication where chemotherapy causes a dangerous drop in blood platelets. By comparing the drug against a placebo in patients with gastrointestinal cancers, researchers aimed to see if the treatment could prevent dosage modifications like delays or reductions. The results demonstrated that p...

NEJM March 12 2026 Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism 12.03.2026

This clinical study investigates the safety profiles of two common blood thinners by comparing their potential to cause harmful side effects during the treatment of blood clots. Researchers conducted a large-scale international trial to determine whether patients using apixaban or rivaroxaban faced a higher danger of clinically relevant bleeding over a three-month period. The findings revealed tha...

JAMA Pediatrics March 2026 Screen Use at Bedtime and Sleep Duration and Quality Among Youths 05.03.2026

This study utilized objective video monitoring and wearable sensors to move beyond unreliable self-reporting when investigating how adolescent technology use affects rest. The researchers discovered that while general screen time in the two hours before bed had little impact on sleep, device use while physically in bed significantly reduced total sleep time. The findings highlight that interactive...

NEJM March 5 2026 Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction 05.03.2026

This study investigated whether the timing and method of treating secondary arterial blockages in heart attack patients affects their long-term recovery. Researchers compared two distinct strategies: performing immediate corrective surgery guided by internal pressure measurements versus postponing treatment until after an external cardiac stress MRI. The findings revealed that performing the proce...

NEJM March 5 2026 Finerenone in Type 1 Diabetes and Chronic Kidney Disease 05.03.2026

This clinical study investigates whether the drug finerenone can help protect the kidneys of adults living with type 1 diabetes, a population for whom the medication's effects were previously uncertain. By tracking the urinary albumin-to-creatinine ratio, researchers discovered that those taking the drug experienced a significant reduction in protein leakage compared to those on a placebo. Whi...

JAMA February 2026 Coffee and Tea Intake, Dementia Risk, and Cognitive Function 27.02.2026

This extensive longitudinal study tracked over 130,000 individuals for more than four decades to clarify how different hot beverages impact long-term brain health. The researchers discovered that regular consumption of caffeinated coffee and tea is linked to a statistically significant reduction in dementia risk and better preservation of mental clarity. Interestingly, these protective benefits we...

JAMA February 2026 Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation 27.02.2026

This clinical study investigated the most effective way to manage multiple brain metastases by comparing highly targeted stereotactic radiationagainst a broader approach that treats the entire brain while protecting the hippocampus. By measuring how cancer treatments affect a patient's symptom severity and daily functioning, researchers sought to identify which method preserves a higher qualit...

JAMA February 2026 Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging 27.02.2026

This global study examines the ionizing radiation exposure that patients experience during common medical imaging procedures used to diagnose heart disease. By analyzing data from over 100 countries, the researchers discovered significant disparities in dosage depending on the specific type of technology used and the geographic location of the patient. A major finding is that individuals in low-in...

NEJM February 2026 Tecovirimat for the Treatment of Mpox 26.02.2026

This clinical study investigated whether the drug tecovirimat, originally approved for smallpox based on animal data, effectively treats human clade II mpox. By comparing a group receiving the medication against a group receiving a placebo, researchers meticulously tracked the time required for skin lesions to heal and for pain to subside. Ultimately, the trial revealed that tecovirimat provided n...

NEJM February 2026 Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges 26.02.2026

This study investigates whether a long-acting injectable treatment is more effective than traditional daily pills for HIV patients who struggle with medication adherence. Researchers compared a monthly regimen of cabotegravir and rilpivirine against standard oral therapy in a group of participants who previously had difficulty maintaining low viral levels. The trial was halted early because the in...

NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer 26.02.2026

This clinical study evaluates a promising medical advancement for patients with HER2-positive breast cancer who still have signs of the disease following their initial surgery and treatment. Researchers compared the effectiveness of a newer drug, T-DXd, against the long-standing standard of care, T-DM1, to see which better prevented the cancer from returning. The results were striking, showing tha...

Écoute le podcast This Week In Medicine sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics